SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $338,000 | -83.1% | 10,488 | -78.1% | 0.00% | -75.0% |
| Q2 2020 | $1,996,000 | +29.6% | 47,983 | +401.8% | 0.00% | 0.0% |
| Q1 2018 | $1,540,000 | -21.9% | 9,562 | -20.1% | 0.00% | +100.0% |
| Q4 2017 | $1,972,000 | +296.8% | 11,966 | +71.1% | 0.00% | +100.0% |
| Q1 2017 | $497,000 | +13.0% | 6,995 | -18.9% | 0.00% | 0.0% |
| Q4 2016 | $440,000 | +14.0% | 8,624 | +3.1% | 0.00% | 0.0% |
| Q3 2016 | $386,000 | -34.1% | 8,363 | -57.0% | 0.00% | 0.0% |
| Q2 2016 | $586,000 | -6.5% | 19,430 | -0.6% | 0.00% | 0.0% |
| Q1 2016 | $627,000 | -44.7% | 19,554 | +0.5% | 0.00% | -66.7% |
| Q4 2015 | $1,134,000 | +35.3% | 19,448 | -1.8% | 0.00% | +50.0% |
| Q3 2015 | $838,000 | -40.6% | 19,806 | +2.6% | 0.00% | -33.3% |
| Q2 2015 | $1,410,000 | – | 19,306 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |